Biodexa Pharmaceuticals Statistics
Total Valuation
BDRX has a market cap or net worth of $2.06 million. The enterprise value is -$9.34 million.
| Market Cap | 2.06M |
| Enterprise Value | -9.34M |
Important Dates
The last earnings date was Friday, September 12, 2025, before market open.
| Earnings Date | Sep 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BDRX has 828,922 shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 828,922 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +234.24% |
| Owned by Insiders (%) | 0.33% |
| Owned by Institutions (%) | 2.97% |
| Float | 774,663 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.07 |
| P/TBV Ratio | 0.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.03, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.03 |
| Quick Ratio | 1.43 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -37.75 |
Financial Efficiency
Return on equity (ROE) is -64.72% and return on invested capital (ROIC) is -294.85%.
| Return on Equity (ROE) | -64.72% |
| Return on Assets (ROA) | -32.79% |
| Return on Invested Capital (ROIC) | -294.85% |
| Return on Capital Employed (ROCE) | -71.74% |
| Weighted Average Cost of Capital (WACC) | 21.83% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$781,109 |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -141,319 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.32% in the last 52 weeks. The beta is 1.21, so BDRX's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | -94.32% |
| 50-Day Moving Average | 3.22 |
| 200-Day Moving Average | 13.37 |
| Relative Strength Index (RSI) | 35.07 |
| Average Volume (20 Days) | 227,916 |
Short Selling Information
The latest short interest is 7,836, so 9.02% of the outstanding shares have been sold short.
| Short Interest | 7,836 |
| Short Previous Month | 10,140 |
| Short % of Shares Out | 9.02% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.30 |
Income Statement
| Revenue | n/a |
| Gross Profit | -5.33M |
| Operating Income | -11.64M |
| Pretax Income | -8.73M |
| Net Income | -8.59M |
| EBITDA | -11.57M |
| EBIT | -11.64M |
| Earnings Per Share (EPS) | -$78.31 |
Balance Sheet
The company has $11.49 million in cash and $82,100 in debt, with a net cash position of $11.40 million or $13.76 per share.
| Cash & Cash Equivalents | 11.49M |
| Total Debt | 82,100 |
| Net Cash | 11.40M |
| Net Cash Per Share | $13.76 |
| Equity (Book Value) | 15.35M |
| Book Value Per Share | 33.99 |
| Working Capital | 8.50M |
Cash Flow
In the last 12 months, operating cash flow was -$7.52 million and capital expenditures -$2,692, giving a free cash flow of -$7.50 million.
| Operating Cash Flow | -7.52M |
| Capital Expenditures | -2,692 |
| Depreciation & Amortization | 69,706 |
| Net Borrowing | -932,988 |
| Free Cash Flow | -7.50M |
| FCF Per Share | -$9.04 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BDRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -416.29% |
| FCF Yield | -363.24% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 6, 2026. It was a reverse split with a ratio of 1:5.
| Last Split Date | Apr 6, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |